$CDLX
Cardlytics, Inc. Stock $cdlx

$cdlx Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000166607124000037 Filed on March 14, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$67.61M	$89.17M	$309.2M
YoY Change	5.09%	8.08%	3.57%
Cost Of Revenue	$30.54M	$41.88M	$150.6M
YoY Change	-8.51%	8.51%	-0.67%
Gross Profit	$37.07M	$47.29M	$158.6M
YoY Change	19.77%	7.7%	7.95%
Gross Profit Margin	54.82%	53.03%	51.3%
Selling, General & Admin	$28.60M	$37.81M	$116.2M
YoY Change	5.87%	-4.93%	-25.58%
% of Gross Profit	77.17%	79.96%	73.28%
Research & Development	$13.05M	$12.51M	$51.35M
YoY Change	12.83%	1.71%	-5.66%
% of Gross Profit	35.2%	26.46%	32.37%
Depreciation & Amortization	$6.250M	$6.695M	$26.46M
YoY Change	-4.94%	-2.25%	-29.52%
% of Gross Profit	16.86%	14.16%	16.68%
Operating Expenses	$41.65M	$73.31M	$167.6M
YoY Change	7.95%	50.2%	-20.43%
Operating Profit	-$22.83M	-$26.02M	-$135.7M
YoY Change	-286.69%	430.93%	-70.36%
Interest Expense	-$1.449M	$2.086M	$968.0K
YoY Change	-204.92%	-52.11%	-110.84%
% of Operating Profit
Other Income/Expense, Net	-$1.449M		$968.0K
YoY Change	-204.92%		-110.84%
Pretax Income	-$24.28M	-$100.8M	-$134.7M
YoY Change	-278.39%	-73.34%	-71.14%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	-$24.28M	-$100.8M	-$134.7M
YoY Change	-278.39%	-73.34%	-71.05%
Net Earnings / Revenue	-35.91%	-113.09%	-43.56%
Basic Earnings Per Share	-$0.56		-$3.69
Diluted Earnings Per Share	-$0.56	-$2.56	-$3.69
COMMON SHARES
Basic Shares Outstanding	44.11M shares	39.25M shares	36.49M shares
Diluted Shares Outstanding	43.25M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$97.77M	$91.83M	$91.83M
YoY Change	-29.76%	-24.67%	-24.67%
Cash & Equivalents	$97.77M	$91.83M	$91.83M
Short-Term Investments
Other Short-Term Assets	$9.491M	$6.097M	$6.097M
YoY Change	13.76%	-24.34%	-24.34%
Inventory
Prepaid Expenses
Receivables	$105.2M	$120.6M	$120.6M
Other Receivables	$5.834M	$5.379M	$5.379M
Total Short-Term Assets	$218.3M	$223.9M	$223.9M
YoY Change	-11.42%	-10.44%	-10.44%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.906M	$3.323M	$10.63M
YoY Change	-38.89%	-43.83%	-14.85%
Goodwill	$277.2M	$277.2M
YoY Change	-21.41%	-21.41%
Intangibles	$32.22M	$35.00M
YoY Change	-35.57%	-34.54%
Long-Term Investments
YoY Change
Other Assets	$3.023M	$2.735M	$2.735M
YoY Change	15.34%	5.76%	5.76%
Total Long-Term Assets	$350.7M	$350.2M	$350.2M
YoY Change	-19.97%	-20.62%	-20.62%
TOTAL ASSETS
Total Short-Term Assets	$218.3M	$223.9M	$223.9M
Total Long-Term Assets	$350.7M	$350.2M	$350.2M
Total Assets	$569.0M	$574.1M	$574.1M
YoY Change	-16.89%	-16.94%	-16.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.974M	$4.425M	$4.425M
YoY Change	91.7%	17.53%	17.53%
Accrued Expenses	$4.317M	$9.587M	$23.37M
YoY Change	-80.37%	-55.06%	-36.32%
Deferred Revenue	$1.994M	$2.405M
YoY Change	-27.99%	37.35%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$9.000K	$10.00K	$10.00K
YoY Change		-73.68%	-73.68%
Total Short-Term Liabilities	$102.6M	$171.1M	$171.1M
YoY Change	-46.26%	-31.25%	-31.25%
LONG-TERM LIABILITIES
Long-Term Debt	$257.9M	$257.6M	$257.6M
YoY Change	0.58%	13.95%	13.95%
Other Long-Term Liabilities	$9.370M	$10.62M	$10.62M
YoY Change	86.43%		129.03%
Total Long-Term Liabilities	$267.3M	$268.2M	$268.2M
YoY Change	2.23%		16.26%
TOTAL LIABILITIES
Total Short-Term Liabilities	$102.6M	$171.1M	$171.1M
Total Long-Term Liabilities	$267.3M	$268.2M	$268.2M
Total Liabilities	$369.8M	$439.3M	$439.3M
YoY Change	-18.23%	-8.4%	-8.4%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.136B	-$1.111B
YoY Change	17.92%	13.79%
Common Stock	$1.332B	$1.244B
YoY Change	11.81%	5.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$199.1M	$134.8M	$134.8M
YoY Change
Total Liabilities & Shareholders Equity	$569.0M	$574.1M	$574.1M
YoY Change	-16.89%	-16.94%	-16.94%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$24.28M	-$100.8M	-$134.7M
YoY Change	-278.39%	-73.34%	-71.05%
Depreciation, Depletion And Amortization	$6.250M	$6.695M	$26.46M
YoY Change	-4.94%	-2.25%	-29.52%
Cash From Operating Activities	-$17.62M	$2.934M	-$185.0K
YoY Change	75.05%	-122.4%	-99.66%
INVESTING ACTIVITIES
Capital Expenditures	$651.0K	$3.697M	$667.0K
YoY Change	80.83%	17.25%	-43.04%
Acquisitions			$0.00
YoY Change			-100.0%
Other Investing Activities		$2.330M	$2.330M
YoY Change			-202.46%
Cash From Investing Activities	-$4.747M	-$1.367M	-$10.06M
YoY Change	69.41%	-56.64%	-36.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			-$55.00K
YoY Change			-100.14%
Debt Paid & Issued, Net	$0.00		$31.00K
YoY Change	-100.0%		-11.43%
Cash From Financing Activities	$28.32M	48.00K	-$20.03M
YoY Change	-5.54%	-126.82%	-49.92%
NET CHANGE
Cash From Operating Activities	-$17.62M	2.934M	-$185.0K
Cash From Investing Activities	-$4.747M	-1.367M	-$10.06M
Cash From Financing Activities	$28.32M	48.00K	-$20.03M
Net Change In Cash	$5.936M	1.615M	-$30.16M
YoY Change	-65.67%	-109.83%	-72.97%
FREE CASH FLOW
Cash From Operating Activities	-$17.62M	$2.934M	-$185.0K
Capital Expenditures	$651.0K	$3.697M	$667.0K
Free Cash Flow	-$18.27M	-$763.0K	-$852.0K
YoY Change	75.25%	-95.31%	-98.45%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3304000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	968000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8932000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-134702000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-466710000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-136429000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1446000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7864000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-465264000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-128565000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-128565000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	690700000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	157192000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1171000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3108000	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
CY2023	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	11725000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-465264000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	211605000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2155000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	50224000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	50264000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1374000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-6589000	usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001666071
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	675 Ponce de Leon Ave. NE
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 4100
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-38386
CY2023	dei	Entity Registrant Name EntityRegistrantName	CARDLYTICS, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-3039436
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	675 Ponce de Leon Ave. NE
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 4100
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Atlanta
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30308
CY2023	dei	City Area Code CityAreaCode	(888)
CY2023	dei	Local Phone Number LocalPhoneNumber	792-5802
CY2023	dei	Security12b Title Security12bTitle	Common Stock
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	232500000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	44109102	shares
CY2023	dei	Auditor Firm AuditorFirmId	34
CY2023	dei	Auditor Name AuditorName	DELOITTE & TOUCHE LLP
CY2023	dei	Auditor Location AuditorLocation	Atlanta, Georgia
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	91830000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	121905000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	80000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	120622000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	115609000	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	5379000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	4470000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6097000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7978000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	223928000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	250042000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3323000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5916000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7310000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6571000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	35003000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	53475000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	277202000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	352721000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	24643000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	19925000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2735000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2586000	usd
CY2023Q4	us-gaap	Assets Assets	574144000	usd
CY2022Q4	us-gaap	Assets Assets	691236000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4425000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3765000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	11662000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	10486000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9587000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	21335000	usd
CY2023Q4	cdlx	Financial Institution Share Liability Current FinancialInstitutionShareLiabilityCurrent	48867000	usd
CY2022Q4	cdlx	Financial Institution Share Liability Current FinancialInstitutionShareLiabilityCurrent	48593000	usd
CY2023Q4	cdlx	Customer Incentive Liability CustomerIncentiveLiability	52678000	usd
CY2022Q4	cdlx	Customer Incentive Liability CustomerIncentiveLiability	53983000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2405000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1751000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2127000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4910000	usd
CY2023Q4	cdlx	Contingent Consideration Liability Current ContingentConsiderationLiabilityCurrent	39398000	usd
CY2022Q4	cdlx	Contingent Consideration Liability Current ContingentConsiderationLiabilityCurrent	104121000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	171149000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	248944000	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	227504000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	226047000	usd
CY2023Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	30073000	usd
CY2022Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	0	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	67000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	334000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6391000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4306000	usd
CY2023Q4	cdlx	Contingent Consideration Liability Long Term ContingentConsiderationLiabilityLongTerm	4162000	usd
CY2022Q4	cdlx	Contingent Consideration Liability Long Term ContingentConsiderationLiabilityLongTerm	0	usd
CY2023Q4	us-gaap	Liabilities Liabilities	439346000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	479631000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	9000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1182568000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5598000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-976570000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	211605000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	691236000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	51352000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	58810000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	81446000	usd
CY2023	cdlx	Acquisition Integration And Divestiture Costs Benefit AcquisitionIntegrationAndDivestitureCostsBenefit	-6313000	usd
CY2022	cdlx	Acquisition Integration And Divestiture Costs Benefit AcquisitionIntegrationAndDivestitureCostsBenefit	-2874000	usd
CY2021	cdlx	Acquisition Integration And Divestiture Costs Benefit AcquisitionIntegrationAndDivestitureCostsBenefit	24372000	usd
CY2023	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	1246000	usd
CY2022	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-128174000	usd
CY2021	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	1374000	usd
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	70518000	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	453288000	usd
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2023	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-6550000	usd
CY2022	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2021	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-135670000	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2336000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2556000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6376000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1267000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13830000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-134702000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-134702000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-465264000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.69
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-13.92
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.99
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36488000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33419000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32202000	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-134702000	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-3131000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	5112000	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	678000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-137833000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-460152000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-127887000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	211605000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	54000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	43466000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	15171000	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2335000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3131000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-134702000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	418000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	46810000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	1997000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	1997000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	5112000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	841000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	678000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-128565000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	690700000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-134702000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-465264000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-128565000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1704000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2399000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1702000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	26460000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	37544000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	29871000	usd
CY2023	cdlx	Capitalized Contract Cost Amortization Interest Expense CapitalizedContractCostAmortizationInterestExpense	1648000	usd
CY2022	cdlx	Capitalized Contract Cost Amortization Interest Expense CapitalizedContractCostAmortizationInterestExpense	1595000	usd
CY2021	cdlx	Capitalized Contract Cost Amortization Interest Expense CapitalizedContractCostAmortizationInterestExpense	968000	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	3055000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	6196000	usd
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	5783000	usd
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	70518000	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	453288000	usd
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2023	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-6550000	usd
CY2022	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2021	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	9513000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	40980000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	44686000	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1246000	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-128174000	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	4170000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1343000	usd
CY2023	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	0	usd
CY2022	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	0	usd
CY2021	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	3785000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1446000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7864000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7725000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4546000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	27936000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2492000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-535000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1466000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	239000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-893000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1260000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-7492000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-9516000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-905000	usd
CY2023	cdlx	Increase Decrease In Financial Institution Share Liability IncreaseDecreaseInFinancialInstitutionShareLiability	405000	usd
CY2022	cdlx	Increase Decrease In Financial Institution Share Liability IncreaseDecreaseInFinancialInstitutionShareLiability	1721000	usd
CY2021	cdlx	Increase Decrease In Financial Institution Share Liability IncreaseDecreaseInFinancialInstitutionShareLiability	9139000	usd
CY2023	cdlx	Increase Decrease In Consumer Incentive Liability IncreaseDecreaseInConsumerIncentiveLiability	-1393000	usd
CY2022	cdlx	Increase Decrease In Consumer Incentive Liability IncreaseDecreaseInConsumerIncentiveLiability	1382000	usd
CY2021	cdlx	Increase Decrease In Consumer Incentive Liability IncreaseDecreaseInConsumerIncentiveLiability	13211000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-185000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-53904000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-38523000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	667000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	175000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	133000	usd
CY2022	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	12140000	usd
CY2021	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	9323000	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2274000	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	494131000	usd
CY2023	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	2330000	usd
CY2022	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	0	usd
CY2021	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10062000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15760000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-506695000	usd
CY2023	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	30000000	usd
CY2022	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	0	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	31000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	35000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	55000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	379000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	486388000	usd
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	50050000	usd
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	157000	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	190000	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	174000	usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	200000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-20026000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-39987000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	485998000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	118000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1926000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-567000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-30155000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-111577000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-59787000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	121985000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	91830000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	121985000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	233562000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	91830000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	121905000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	233467000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	80000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	95000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	233562000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	4240000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	2381000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	2328000	usd
CY2023Q4	cdlx	Property And Equipment Incurred But Not Yet Paid PropertyAndEquipmentIncurredButNotYetPaid	579000	usd
CY2022Q4	cdlx	Property And Equipment Incurred But Not Yet Paid PropertyAndEquipmentIncurredButNotYetPaid	67000	usd
CY2021Q4	cdlx	Property And Equipment Incurred But Not Yet Paid PropertyAndEquipmentIncurredButNotYetPaid	267000	usd
CY2023Q4	cdlx	Capitalized Software Development Costs Incurredbut Notyet Paid CapitalizedSoftwareDevelopmentCostsIncurredbutNotyetPaid	40000	usd
CY2022Q4	cdlx	Capitalized Software Development Costs Incurredbut Notyet Paid CapitalizedSoftwareDevelopmentCostsIncurredbutNotyetPaid	155000	usd
CY2021Q4	cdlx	Capitalized Software Development Costs Incurredbut Notyet Paid CapitalizedSoftwareDevelopmentCostsIncurredbutNotyetPaid	253000	usd
CY2022Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	40000000	usd
CY2022Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	40000000	usd
CY2022Q2	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	1405655	shares
CY2021Q1	us-gaap	Payments For Commissions PaymentsForCommissions	16300000	usd
CY2023	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	6600000	usd
CY2023Q4	cdlx	First Anniversary Annualized Recurring Revenue Cash Paid FirstAnniversaryAnnualizedRecurringRevenueCashPaid	50100000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated financial statements. Significant items subject to such estimates and assumptions include revenue recognition, internal-use software development costs, stock-based compensation, allowance for doubtful accounts, valuation of acquired intangible assets of Dosh and Bridg, valuation of contingent consideration for Bridg, valuation of long-lived assets, goodwill valuation, income tax including valuation allowance and contingencies. We base our estimates on historical experience and on assumptions that we believe are reasonable. Changes in facts or circumstances may cause us to change our assumptions and estimates in future periods and it is possible that actual results could differ from our current or revised future estimates</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Restructuring and Reduction of Force</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a part of our integration efforts with our acquired companies, we continued to evaluate the optimal structure of the combined organization. As a result, during 2022, we initiated a strategic reduction of our workforce in our U.S., U.K., and India operations, including the planned closure of our Indian office. We also began a strategic shift within our organization to migrate certain data and applications to a cloud computing environment. As part of these initiatives, we recognized severance and medical benefit costs of $8.1 million. These charges are reflected on our condensed consolidated statements of operations as follows: $1.9 million in delivery costs, $2.1 million in sales and marketing expense, $1.6 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in research and development expense and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2.5 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in general and administrative expense. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize these costs when the extent of our actions are determined and the costs can be estimated. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We closed our India office as of December 31, 2022. As of December 31, 2022, the remaining costs that have been incurred related to our restructuring and reduction of force but not yet paid were $2.4 million. T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hese fees were paid in full in 2023.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, we recognized $1.2 million in severance and medical benefits related to our acquisitions. These charges are reflected on our consolidated statements of operations within acquisition and integration costs. Additionally, during the year ended December 31, 2021, we recognized $0.8 million of severance and medical benefits charges related to internal restructuring. These charges are reflected on our consolidated statements of operations as follows: $0.1 million in delivery costs, $0.4 million in sales and marketing expense, and $0.3 million in research and development expense. We recognize these costs when the extent of our actions is determined and the costs can be estimated.</span></div>
CY2023Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	8100000	usd
CY2022Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	1200000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Realized After Tax ForeignCurrencyTransactionGainLossRealizedAfterTax	3300000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Realized After Tax ForeignCurrencyTransactionGainLossRealizedAfterTax	6400000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Realized After Tax ForeignCurrencyTransactionGainLossRealizedAfterTax	1300000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	56400000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	70500000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	396200000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1808000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1327000	usd
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	587000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1704000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2399000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1702000	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1273000	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1918000	usd
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	962000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2239000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1808000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1327000	usd
CY2023Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	200000	usd
CY2022Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	1600000	usd
CY2021Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	2200000	usd
CY2023	cdlx	Number Of Patents Approved NumberOfPatentsApproved	16	patent
CY2022	cdlx	Number Of Patents Approved NumberOfPatentsApproved	1	patent
CY2022Q4	cdlx	Finite Lived Intangible Assets Not Yet Capitalized FiniteLivedIntangibleAssetsNotYetCapitalized	100000	usd
CY2021Q4	cdlx	Finite Lived Intangible Assets Not Yet Capitalized FiniteLivedIntangibleAssetsNotYetCapitalized	100000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	46373000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	32895000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	21730000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	12970000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	24643000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	19925000	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	230000000	usd
CY2023Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0100
CY2020Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	222700000	usd
CY2023Q4	cdlx	Debt Issuance Costs Amortization Year Two DebtIssuanceCostsAmortizationYearTwo	1462000	usd
CY2023Q4	cdlx	Debt Issuance Costs Amortization Year Three DebtIssuanceCostsAmortizationYearThree	1034000	usd
CY2023Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	2496000	usd
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1900000	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	4700000	usd
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	3700000	usd
CY2023	cdlx	Acquisition Integration And Divestiture Costs Benefit AcquisitionIntegrationAndDivestitureCostsBenefit	-6300000	usd
CY2022	cdlx	Acquisition Integration And Divestiture Costs Benefit AcquisitionIntegrationAndDivestitureCostsBenefit	-2900000	usd
CY2023	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	6600000	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	298563000	usd
CY2021	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	276563000	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-465563000	usd
CY2021	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-134925000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	352721000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	70518000	usd
CY2023	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	5001000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	277202000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	742516000	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	5062000	usd
CY2022	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Consideration Transferred BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred	1385000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	396242000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	352721000	usd
CY2020Q4	us-gaap	Goodwill Goodwill	0	usd
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	742516000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	742516000	usd
CY2023	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	6600000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	56400000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	11117000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	11117000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	9674000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3021000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	0	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	0	usd
CY2023	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	144200000	usd
CY2022	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	143900000	usd
CY2021	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	127000000.0	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	285425000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	277185000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	258754000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	41000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	28000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	30400000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	4500000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	8200000	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	3295000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	6598000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	1191000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	1294000	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	600000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	459000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	5086000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	8351000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.068
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.042
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y21D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M3D
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2225000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2184000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1347000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1170000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	3394000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	10320000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1802000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	8518000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	36390000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	35437000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	33067000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	29521000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3323000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5916000	usd
CY2023	us-gaap	Depreciation Nonproduction DepreciationNonproduction	3700000	usd
CY2022	us-gaap	Depreciation Nonproduction DepreciationNonproduction	5400000	usd
CY2021	us-gaap	Depreciation Nonproduction DepreciationNonproduction	6700000	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	227504000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	226047000	usd
CY2023Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	257504000	usd
CY2022Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	226047000	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	230000000	usd
CY2023Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0100
CY2023Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0100
CY2020Q3	us-gaap	Debt Instrument Convertible Threshold Consecutive Trading Days1 DebtInstrumentConvertibleThresholdConsecutiveTradingDays1	30000	numberofdays
CY2020Q3	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	1.30
CY2020Q3	us-gaap	Debt Instrument Convertible Conversion Ratio1 DebtInstrumentConvertibleConversionRatio1	11.7457
CY2020Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	85140
CY2020Q3	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	1.30
CY2020Q3	us-gaap	Debt Instrument Convertible Threshold Consecutive Trading Days1 DebtInstrumentConvertibleThresholdConsecutiveTradingDays1	30000	numberofdays
CY2020Q3	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	1
CY2020Q3	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	1
CY2020Q3	us-gaap	Debt Instrument Convertible Threshold Consecutive Trading Days1 DebtInstrumentConvertibleThresholdConsecutiveTradingDays1	30000	numberofdays
CY2020Q3	us-gaap	Debt Instrument Convertible Threshold Consecutive Trading Days1 DebtInstrumentConvertibleThresholdConsecutiveTradingDays1	30000	numberofdays
CY2020Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	222700000	usd
CY2020Q3	us-gaap	Debt Instrument Call Feature DebtInstrumentCallFeature	26.5 million
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	230000000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	230000000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2496000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3953000	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	227504000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	226047000	usd
CY2023	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	2300000	usd
CY2022	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	2300000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1461000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1461000	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	3761000	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	3761000	usd
CY2023Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0164
CY2022Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0164
CY2020Q3	us-gaap	Debt Instrument Call Feature DebtInstrumentCallFeature	26.5 million
CY2023Q4	cdlx	Line Of Credit Facility Maximum Borrowing Capacity Percentage Of Eligible Accounts Receivable LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleAccountsReceivable	0.50
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	961558	shares
CY2023Q4	cdlx	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Annual Percentage Increase ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedAnnualPercentageIncrease	0.05
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	1986417	shares
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	40980000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	44686000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	50264000	usd
CY2019Q2	cdlx	Sharebased Compensation Arrangementby Sharebased Payment Award Monthly Average Closing Price Common Stock Threshold SharebasedCompensationArrangementbySharebasedPaymentAwardMonthlyAverageClosingPriceCommonStockThreshold	9.21
CY2023	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	657826	shares
CY2020Q1	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	397283000	shares
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-122026000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-455202000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-122087000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-12676000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-11508000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-14342000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-134702000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-466710000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-136429000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	10236000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	38508000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	31106000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	335000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	6317000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	4942000	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	961000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	3075000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	2184000	usd
CY2023	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	-1320000	usd
CY2022	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	-587000	usd
CY2021	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	-596000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	10212000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	45867000	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	29772000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1446000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7864000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1446000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7864000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0001
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0008
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0208
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.0001
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.0015
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.0014
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0022
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.0001
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0019
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	-0.1094
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	-0.1782
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.0081
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0.0571
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0140
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0103
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0468
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.0754
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.0987
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2175
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0009
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0029
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0568
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	158916000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	155949000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	809000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	776000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	11574000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1485000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3566000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	7020000	usd
CY2023Q4	cdlx	Deferred Tax Assets Change In Fair Value Of Convertible Promissory Notes DeferredTaxAssetsChangeInFairValueOfConvertiblePromissoryNotes	3735000	usd
CY2022Q4	cdlx	Deferred Tax Assets Change In Fair Value Of Convertible Promissory Notes DeferredTaxAssetsChangeInFairValueOfConvertiblePromissoryNotes	6018000	usd
CY2023Q4	cdlx	Deferred Tax Asset Right Of Use Asset DeferredTaxAssetRightOfUseAsset	-1565000	usd
CY2022Q4	cdlx	Deferred Tax Asset Right Of Use Asset DeferredTaxAssetRightOfUseAsset	-1429000	usd
CY2023Q4	cdlx	Deferred Tax Asset Lease Liability DeferredTaxAssetLeaseLiability	1856000	usd
CY2022Q4	cdlx	Deferred Tax Asset Lease Liability DeferredTaxAssetLeaseLiability	2010000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	9641000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	5683000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1129000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1936000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	189660000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	179448000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	179448000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	123867000	usd
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	85991000	usd
CY2023	cdlx	Valuation Allowance Increase Decrease In Allowance For Operating Loss Carryforwards ValuationAllowanceIncreaseDecreaseInAllowanceForOperatingLossCarryforwards	-2442000	usd
CY2022	cdlx	Valuation Allowance Increase Decrease In Allowance For Operating Loss Carryforwards ValuationAllowanceIncreaseDecreaseInAllowanceForOperatingLossCarryforwards	-13360000	usd
CY2021	cdlx	Valuation Allowance Increase Decrease In Allowance For Operating Loss Carryforwards ValuationAllowanceIncreaseDecreaseInAllowanceForOperatingLossCarryforwards	-51856000	usd
CY2023	cdlx	Valuation Allowance Increase Decrease In Tax Rate Change ValuationAllowanceIncreaseDecreaseInTaxRateChange	-424000	usd
CY2022	cdlx	Valuation Allowance Increase Decrease In Tax Rate Change ValuationAllowanceIncreaseDecreaseInTaxRateChange	235000	usd
CY2021	cdlx	Valuation Allowance Increase Decrease In Tax Rate Change ValuationAllowanceIncreaseDecreaseInTaxRateChange	419000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	0	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-9714000	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	0	usd
CY2023	cdlx	Valuation Allowance Other Increase Decrease ValuationAllowanceOtherIncreaseDecrease	-7346000	usd
CY2022	cdlx	Valuation Allowance Other Increase Decrease ValuationAllowanceOtherIncreaseDecrease	-32742000	usd
CY2021	cdlx	Valuation Allowance Other Increase Decrease ValuationAllowanceOtherIncreaseDecrease	13561000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	189660000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	179448000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	123867000	usd
CY2023Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	1400000	usd
CY2022Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	900000	usd
CY2021Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	1300000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1606000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1128000	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	302000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1319000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	478000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	826000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2925000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1606000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1128000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	70500000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	396200000	usd
CY2022Q4	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	104121000	usd
CY2021Q4	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	232295000	usd
CY2023	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration	-61807000	usd
CY2022	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration	0	usd
CY2023	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	1246000	usd
CY2022	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-128174000	usd
CY2023Q4	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	43560000	usd
CY2022Q4	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	104121000	usd
CY2023Q4	cdlx	First Anniversary Annualized Recurring Revenue Cash Paid FirstAnniversaryAnnualizedRecurringRevenueCashPaid	50100000	usd
CY2023Q4	cdlx	Business Acquisition Equity Interest Issued Or Issuable Number Of Shares Delivered BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesDelivered	2740418	shares
CY2022Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	0	usd
CY2021Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	0	usd
CY2020Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	3785000	usd
CY2023	cdlx	Contractwith Customer Asset Deferred Financial Institution Implementation Costs Recoveries Through Financial Institution Share Net ContractwithCustomerAssetDeferredFinancialInstitutionImplementationCostsRecoveriesThroughFinancialInstitutionShareNet	0	usd
CY2022	cdlx	Contractwith Customer Asset Deferred Financial Institution Implementation Costs Recoveries Through Financial Institution Share Net ContractwithCustomerAssetDeferredFinancialInstitutionImplementationCostsRecoveriesThroughFinancialInstitutionShareNet	0	usd
CY2021	cdlx	Contractwith Customer Asset Deferred Financial Institution Implementation Costs Recoveries Through Financial Institution Share Net ContractwithCustomerAssetDeferredFinancialInstitutionImplementationCostsRecoveriesThroughFinancialInstitutionShareNet	0	usd
CY2023	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	0	usd
CY2021	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	usd
CY2022	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	0	usd
CY2021	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	2826000	usd
CY2023	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	0	usd
CY2022	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	0	usd
CY2021	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	959000	usd
CY2022	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-128174000	usd
CY2021	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	1374000	usd
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	70518000	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	453288000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	0	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	0	usd
CY2021Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	0	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	230000000	usd
CY2023Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0100
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2023	us-gaap	Revenues Revenues	309204000	usd
CY2022	us-gaap	Revenues Revenues	298542000	usd
CY2021	us-gaap	Revenues Revenues	267116000	usd
CY2023	cdlx	Financial Institution Share And Other Third Party Costs Excluding Noncash Equity Expenseand Deferred Implementation Costs FinancialInstitutionShareAndOtherThirdPartyCostsExcludingNoncashEquityExpenseandDeferredImplementationCosts	150578000	usd
CY2022	cdlx	Financial Institution Share And Other Third Party Costs Excluding Noncash Equity Expenseand Deferred Implementation Costs FinancialInstitutionShareAndOtherThirdPartyCostsExcludingNoncashEquityExpenseandDeferredImplementationCosts	155507000	usd
CY2021	cdlx	Financial Institution Share And Other Third Party Costs Excluding Noncash Equity Expenseand Deferred Implementation Costs FinancialInstitutionShareAndOtherThirdPartyCostsExcludingNoncashEquityExpenseandDeferredImplementationCosts	137488000	usd
CY2023	cdlx	Adjusted Contribution AdjustedContribution	158626000	usd
CY2022	cdlx	Adjusted Contribution AdjustedContribution	143035000	usd
CY2021	cdlx	Adjusted Contribution AdjustedContribution	129628000	usd
CY2023	cdlx	Adjusted Contribution AdjustedContribution	158626000	usd
CY2022	cdlx	Adjusted Contribution AdjustedContribution	143035000	usd
CY2021	cdlx	Adjusted Contribution AdjustedContribution	129628000	usd
CY2023	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	0	usd
CY2022	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	0	usd
CY2021	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	3785000	usd
CY2023	cdlx	Delivery Costs DeliveryCosts	28248000	usd
CY2022	cdlx	Delivery Costs DeliveryCosts	30403000	usd
CY2021	cdlx	Delivery Costs DeliveryCosts	22503000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	57425000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	74745000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	65996000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	51352000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	54435000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	38104000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	58810000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	81446000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	66222000	usd
CY2023	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	1246000	usd
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2023	cdlx	Acquisition Integration And Divestiture Costs Benefit AcquisitionIntegrationAndDivestitureCostsBenefit	-6313000	usd
CY2022	cdlx	Acquisition Integration And Divestiture Costs Benefit AcquisitionIntegrationAndDivestitureCostsBenefit	-2874000	usd
CY2021	cdlx	Acquisition Integration And Divestiture Costs Benefit AcquisitionIntegrationAndDivestitureCostsBenefit	24372000	usd
CY2023	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	6550000	usd
CY2022	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	26460000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	37544000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	29871000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	968000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8932000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13830000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-134702000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-466710000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-136429000	usd
CY2023	us-gaap	Revenues Revenues	309204000	usd
CY2022	us-gaap	Revenues Revenues	298542000	usd
CY2021	us-gaap	Revenues Revenues	267116000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3323000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5916000	usd

Files In Submission

Name	View Source	Status
0001666071-24-000037-index-headers.html	Edgar Link	pending
0001666071-24-000037-index.html	Edgar Link	pending
0001666071-24-000037.txt	Edgar Link	pending
0001666071-24-000037-xbrl.zip	Edgar Link	pending
cdlx-20231231.htm	Edgar Link	pending
cdlx-20231231.xsd	Edgar Link	pending
cdlx-20231231_g1.jpg	Edgar Link	pending
cdlx-20231231_g2.jpg	Edgar Link	pending
cdlx-20231231_cal.xml	Edgar Link	unprocessable
cdlx-20231231_def.xml	Edgar Link	unprocessable
cdlx-20231231_lab.xml	Edgar Link	unprocessable
cdlx-20231231_htm.xml	Edgar Link	completed
cdlx_form10-kx2023xex1048.htm	Edgar Link	pending
cdlx_form10-kx2023xex1049.htm	Edgar Link	pending
cdlx_form10-kx2023xex1051.htm	Edgar Link	pending
cdlx_form10-kx2023xex1052.htm	Edgar Link	pending
cdlx_form10-kx2023xex1053.htm	Edgar Link	pending
cdlx_form10-kx2023xex231.htm	Edgar Link	pending
cdlx_form10-kx2023xex311.htm	Edgar Link	pending
cdlx_form10-kx2023xex312.htm	Edgar Link	pending
cdlx_form10-kx2023xex321.htm	Edgar Link	pending
cdlx_form10-kx2023xex971.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0.jpg	Edgar Link	pending
image_0a.jpg	Edgar Link	pending
image_2.jpg	Edgar Link	pending
image_3.jpg	Edgar Link	pending
image_4.jpg	Edgar Link	pending
image_6.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cdlx-20231231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CDLX
Cardlytics, Inc. Stock $cdlx

2024 Q1 Form 10-K Financial Statement

#000166607124000037 Filed on March 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDLX Cardlytics, Inc. Stock $cdlx

2024 Q1 Form 10-K Financial Statement

#000166607124000037 Filed on March 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDLX
Cardlytics, Inc. Stock $cdlx